Deals
Skystar Bio-Pharmaceutical Raises $4M in RDO at 16% Discount via H.C. Wainwright
|
Skystar Bio-Pharmaceutical Company Limited (SKBI) announced that it has raised $4,000,001 in a Registered Direct transaction.
Growth Capitalist (https://growthcapitalist.com/tag/china/page/5/)
Skystar Bio-Pharmaceutical Company Limited (SKBI) announced that it has raised $4,000,001 in a Registered Direct transaction.
General Steel Holdings, Inc. (GSI) announced that it has raised $7,500,000 in a Common Stock transaction.
Equity private placement investors and emerging growth companies continued a brisk pace of deal making in the first half of 2014, maintaining momentum generated by a robust but toppy stock market and a growing appetite for risk.
China-based emerging growth companies (EGCs) are riding a wave of investor enthusiasm for Chinese internet companies led by excitement over the impending IPO of the country’s online commerce juggernaut Alibaba.